pubmed-article:15224143 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15224143 | lifeskim:mentions | umls-concept:C0027950 | lld:lifeskim |
pubmed-article:15224143 | lifeskim:mentions | umls-concept:C0001511 | lld:lifeskim |
pubmed-article:15224143 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
pubmed-article:15224143 | lifeskim:mentions | umls-concept:C0242184 | lld:lifeskim |
pubmed-article:15224143 | lifeskim:mentions | umls-concept:C1704259 | lld:lifeskim |
pubmed-article:15224143 | lifeskim:mentions | umls-concept:C1705987 | lld:lifeskim |
pubmed-article:15224143 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:15224143 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:15224143 | pubmed:dateCreated | 2004-6-29 | lld:pubmed |
pubmed-article:15224143 | pubmed:abstractText | To investigate the inhibition of cyclosporin A (CsA) on neutrophil adhesion to human umbilical vein endothelial cells (HUVECs, ECV-304) induced by hypoxia/reoxygenation and further explore its mechanism, a 1 h hypoxia/4 h reoxygenation model was reproduced using ECV-304. The adhesion rate of neutrophils to ECV-304 was determined by measuring the activity of endogenous hexosaminidase. The expression of endothelial cell adhesion molecules of E-selectin and ICAM-1 was measured by flow cytometry. The expression of cyclophilin A (CyPA) and the activation of ERK1/2 was compared among experimental groups by Western blot. The content of reactive oxygen species (ROS) was measured by Fenton reaction. After being stimulated with 1 h hypoxia/4 h reoxygenation, ECV-304 showed an enhanced neutrophil adhensiveness in association with an increased surface expression of E-selectin and ICAM-1. In parallel, the content of ROS was also increased. These effects were significantly suppressed by the addition of CsA. Most importantly, the expression of CyPA was significantly increased following 1 h hypoxia/4 h reoxygenation, which was accompanied with an increased activation of ERK1/2. Treatment with CyPA inhibitor CsA and CyPA antisense oligonucleotides significantly inhibited the activation of ERK1/2 and decreased the adhesion of neutrophils to ECV-304. The specific ERK1/2 inhibitor PD98059 caused an inhibition of neutrophil adhesion to hypoxia/reoxygenation-stimulated ECV-304. Our data confirm that CsA inhibits neutrophil adhesion to hypoxia/reoxygenation stimulated ECV-304 by a mechanism involving inhibition of the signal transduction of ROS, CyPA and ERK1/2. | lld:pubmed |
pubmed-article:15224143 | pubmed:language | chi | lld:pubmed |
pubmed-article:15224143 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15224143 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15224143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15224143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15224143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15224143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15224143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15224143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15224143 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15224143 | pubmed:month | Jun | lld:pubmed |
pubmed-article:15224143 | pubmed:issn | 0371-0874 | lld:pubmed |
pubmed-article:15224143 | pubmed:author | pubmed-author:YanFeng-Xiang... | lld:pubmed |
pubmed-article:15224143 | pubmed:author | pubmed-author:LiaoDuan-Fang... | lld:pubmed |
pubmed-article:15224143 | pubmed:author | pubmed-author:LeiXiao-YongX... | lld:pubmed |
pubmed-article:15224143 | pubmed:author | pubmed-author:ZhouSi-GuiSG | lld:pubmed |
pubmed-article:15224143 | pubmed:author | pubmed-author:XuLi-PengLP | lld:pubmed |
pubmed-article:15224143 | pubmed:author | pubmed-author:ZhuBing-YangB... | lld:pubmed |
pubmed-article:15224143 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15224143 | pubmed:day | 25 | lld:pubmed |
pubmed-article:15224143 | pubmed:volume | 56 | lld:pubmed |
pubmed-article:15224143 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15224143 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15224143 | pubmed:pagination | 313-20 | lld:pubmed |
pubmed-article:15224143 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:meshHeading | pubmed-meshheading:15224143... | lld:pubmed |
pubmed-article:15224143 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15224143 | pubmed:articleTitle | [Cyclosporin A inhibits the adhesion of neutrophil with ECV-304 induced by hypoxia/reoxygenation via ROS-Cyclophilin A-ERK1/2 pathway]. | lld:pubmed |
pubmed-article:15224143 | pubmed:affiliation | Institute of Pharmacy and Pharmacology, Nanhua University, Hengyang, Hunan 421001, China. | lld:pubmed |
pubmed-article:15224143 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15224143 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:15224143 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |